Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Feb-24 9:50 PM View:  | Perry David P Executive Chairman Director 10% Owner | Better Therapeutics, Inc. (BTTX) | 09-Feb-24 | Grant | 839,895 | $0.19 | $160,000.00 | 5% 18.56M to 19.4M | |
| 10-Jan-24 4:19 PM View: | Perry David P Executive Chairman Director 10% Owner | Better Therapeutics, Inc. (BTTX) | 09-Jan-24 | Grant | 1,471,450 | $0.17 | $250,000.00 | 9% 17.09M to 18.56M | |
| 20-Dec-23 5:21 PM View: | Miller Leslie A. Principal Accounting Officer | Better Therapeutics, Inc. (BTTX) | 18-Dec-23 | Grant | 3,587 | -- | -- | 25% 14.35K to 17.94K | |
| 20-Dec-23 5:23 PM View: | Lavizzo-Mourey Risa J Director | Better Therapeutics, Inc. (BTTX) | 18-Dec-23 | Grant | 3,750 | -- | -- | 38% 10.0K to 13.75K | |
| 20-Dec-23 5:10 PM View: | Berman Mark A. Chief Medical Officer | Better Therapeutics, Inc. (BTTX) | 18-Dec-23 | Grant | 25,362 | -- | -- | 6% 422.78K to 448.14K | |
| 20-Dec-23 5:22 PM View: | Armanino Andrew J. Director | Better Therapeutics, Inc. (BTTX) | 18-Dec-23 | Grant | 3,750 | -- | -- | < 1% 741.7K to 745.45K | |
| 20-Dec-23 5:23 PM View: | Wynholds Kristin Chief Product Officer | Better Therapeutics, Inc. (BTTX) | 18-Dec-23 | Grant | 25,362 | -- | -- | 13% 200.27K to 225.63K | |
| 20-Dec-23 5:24 PM View: | Perry David P Executive Chairman Director 10% Owner | Better Therapeutics, Inc. (BTTX) | 18-Dec-23 | Grant | 3,750 | -- | -- | < 1% 17.08M to 17.09M | |
| 20-Dec-23 5:22 PM View: | Parker Geoffrey M. Director | Better Therapeutics, Inc. (BTTX) | 18-Dec-23 | Grant | 3,750 | -- | -- | < 1% 1.08M to 1.09M | |
| 20-Dec-23 5:15 PM View: | Granger Elder Director | Better Therapeutics, Inc. (BTTX) | 18-Dec-23 | Grant | 3,750 | -- | -- | 10% 35.85K to 39.6K | |
| 20-Dec-23 5:24 PM View: | Carmona Richard H Director | Better Therapeutics, Inc. (BTTX) | 18-Dec-23 | Grant | 3,750 | -- | -- | 2% 153.62K to 157.37K | |
| 20-Dec-23 5:13 PM View: | Karbe Frank Chief Executive Officer Director | Better Therapeutics, Inc. (BTTX) | 18-Dec-23 | Grant | 62,500 | -- | -- | 13% 464.02K to 526.52K | |
| 31-Jul-23 7:59 AM View: | Berman Mark A. Chief Medical Officer | Better Therapeutics, Inc. (BTTX) | 27-Jul-23 | Purchase | 54,802 | $0.73 | $40,000.00 | 16% 333.39K to 388.19K | |
| 31-Jul-23 7:58 AM View: | Armanino Andrew J. Director | Better Therapeutics, Inc. (BTTX) | 27-Jul-23 | Purchase | 274,010 | $0.73 | $200,000.00 | 59% 467.69K to 741.7K | |
| 31-Jul-23 7:59 AM View: | Perry David P Executive Chairman Director 10% Owner | Better Therapeutics, Inc. (BTTX) | 27-Jul-23 | Purchase | 1,233,040 | $0.73 | $900,000.00 | 8% 15.85M to 17.08M | |
| 31-Jul-23 7:58 AM View: | Parker Geoffrey M. Director | Better Therapeutics, Inc. (BTTX) | 27-Jul-23 | Purchase | 685,025 | $0.73 | $500,000.00 | 173% 396.37K to 1.08M | |
| 31-Jul-23 7:58 AM View: | Granger Elder Director | Better Therapeutics, Inc. (BTTX) | 27-Jul-23 | Purchase | 34,251 | $0.73 | $24,999.80 | 2141% 1.6K to 35.85K | |
| 31-Jul-23 7:58 AM View: | Karbe Frank Chief Executive Officer Director | Better Therapeutics, Inc. (BTTX) | 27-Jul-23 | Purchase | 137,005 | $0.73 | $100,000.00 | 47% 292.42K to 429.43K | |
| 18-May-23 7:11 AM View: | Granger Elder Director | Better Therapeutics, Inc. (BTTX) | 16-May-23 | Purchase | 600 | $0.87 | $520.32 | 60% 1.0K to 1.6K | |
| 12-Apr-23 4:15 PM View: | Parker Geoffrey M. Director | Better Therapeutics, Inc. (BTTX) | 10-Apr-23 | Purchase | 303,030 | $0.82 | $250,000.00 | 325% 93.33K to 396.36K | |
| 12-Apr-23 9:44 PM View: | Perry David P See Remarks Director 10% Owner | Better Therapeutics, Inc. (BTTX) | 10-Apr-23 | Purchase | 4,969,700 | $0.82 | $4,100,000.00 | 46% 10.88M to 15.85M | |
| 12-Apr-23 4:15 PM View: | Karbe Frank See Remarks Director | Better Therapeutics, Inc. (BTTX) | 10-Apr-23 | Purchase | 242,424 | $0.82 | $200,000.00 | 485% 50.0K to 292.42K | |
| 12-Apr-23 4:15 PM View: | Armanino Andrew J. Director | Better Therapeutics, Inc. (BTTX) | 10-Apr-23 | Purchase Duplicate | 303,030 | $0.82 | $250,000.00 | 184% 164.66K to 467.69K | |
| 21-Apr-23 6:13 PM View: | Wynholds Kristin Chief Product Officer | Better Therapeutics, Inc. (BTTX) | 05-Apr-23 | Grant | 101,450 | -- | -- | 103% 98.82K to 200.27K | |
| 21-Apr-23 6:13 PM View: | Berman Mark A. Chief Medical Officer | Better Therapeutics, Inc. (BTTX) | 05-Apr-23 | Grant | 101,450 | -- | -- | 44% 231.94K to 333.39K | |
| 21-Apr-23 6:14 PM View: | Heinen Mark Chief Financial Officer | Better Therapeutics, Inc. (BTTX) | 05-Apr-23 | Grant | 54,000 | -- | -- | 61% 88.0K to 142.0K | |
| 02-Dec-22 4:15 PM View: | Heinen Mark See Remarks | Better Therapeutics, Inc. (BTTX) | 30-Nov-22 | Grant | 15,723 | $1.24 | $19,512.20 | 22% 72.28K to 88.0K | |
| 02-Dec-22 4:15 PM View: | Wynholds Kristin Chief Product Officer | Better Therapeutics, Inc. (BTTX) | 30-Nov-22 | Grant | 3,781 | $1.24 | $4,692.22 | 4% 95.04K to 98.82K | |
| 19-Sep-22 6:06 AM View: | Perry David P See Remarks Director 10% Owner | Better Therapeutics, Inc. (BTTX) | 16-Sep-22 | Purchase | 39,156 | $2.07 | $80,974.60 | < 1% 10.84M to 10.88M | |
| 15-Sep-22 8:53 PM View: | Karbe Frank See Remarks Director | Better Therapeutics, Inc. (BTTX) | 15-Sep-22 | Purchase | 50,000 | $2.09 | $104,695.00 | 100% 0 to 50.0K | |
| 19-Sep-22 6:06 AM View: | Perry David P See Remarks Director 10% Owner | Better Therapeutics, Inc. (BTTX) | 15-Sep-22 | Purchase | 10,844 | $1.99 | $21,622.90 | < 1% 10.83M to 10.84M | |
| 14-Sep-22 4:37 PM View: | Heinen Mark See Remarks | Better Therapeutics, Inc. (BTTX) | 13-Sep-22 | Purchase | 26,132 | $1.94 | $50,696.10 | 57% 46.15K to 72.28K | |
| 14-Sep-22 4:37 PM View: | Heinen Mark See Remarks | Better Therapeutics, Inc. (BTTX) | 12-Sep-22 | Purchase | 23,868 | $1.94 | $46,303.90 | 107% 22.28K to 46.15K | |
| 28-Jun-22 4:24 PM View: | Heinen Mark See Remarks | Better Therapeutics, Inc. (BTTX) | 24-Jun-22 | Purchase | 2,281 | $1.75 | $3,999.95 | 11% 20.0K to 22.28K | |
| 16-Jun-22 7:11 PM View: | Armanino Andrew J. Director | Better Therapeutics, Inc. (BTTX) | 14-Jun-22 | Purchase | 15,000 | $1.39 | $20,845.50 | 9% 164.66K to 179.66K | |
| 14-Jun-22 4:25 PM View: | Parker Geoffrey M. Director | Better Therapeutics, Inc. (BTTX) | 13-Jun-22 | Purchase | 25,000 | $1.45 | $36,182.50 | 37% 68.33K to 93.33K | |
| 10-Jun-22 6:23 PM View: | Heinen Mark See Remarks | Better Therapeutics, Inc. (BTTX) | 10-Jun-22 | Purchase | 5,000 | $1.56 | $7,800.00 | 33% 15.0K to 20.0K | |
| 10-Jun-22 4:39 PM View: | Armanino Andrew J. Director | Better Therapeutics, Inc. (BTTX) | 09-Jun-22 | Purchase | 25,000 | $1.65 | $41,355.00 | 18% 139.66K to 164.66K | |
| 02-Dec-22 4:15 PM View: | Wynholds Kristin Chief Product Officer | Better Therapeutics, Inc. (BTTX) | 31-May-22 | Grant | 5,023 | $1.54 | $7,727.89 | 6% 90.02K to 95.04K | |
| 01-Jun-22 4:47 PM View: | Zamirowski Justin Chief Commercial Officer | Better Therapeutics, Inc. (BTTX) | 27-May-22 | Option Exercise | 1,677 | $0.50 | $838.50 | 5% 35.24K to 36.91K | |
| 18-May-22 5:12 PM View: | Zamirowski Justin Chief Commercial Officer | Better Therapeutics, Inc. (BTTX) | 16-May-22 | Option Exercise | 35,236 | $0.50 | $17,618.00 | 100% 0 to 35.24K | |
| 04-Apr-22 4:27 PM View: | Appelbaum Kevin J Chief Executive Officer Director 10% Owner | Better Therapeutics, Inc. (BTTX) | 31-Mar-22 | Purchase | 2,500 | $1.97 | $4,921.25 | < 1% 2.41M to 2.41M | |
| 04-Apr-22 4:28 PM View: | Heinen Mark See Remarks | Better Therapeutics, Inc. (BTTX) | 31-Mar-22 | Purchase | 5,000 | $1.98 | $9,900.00 | 50% 10.0K to 15.0K | |
| 31-Mar-22 4:38 PM View: | Parker Geoffrey M. Director | Better Therapeutics, Inc. (BTTX) | 29-Mar-22 | Purchase | 15,000 | $2.15 | $32,230.50 | 28% 53.33K to 68.33K | |
| 31-Mar-22 4:39 PM View: | Armanino Andrew J. Director | Better Therapeutics, Inc. (BTTX) | 29-Mar-22 | Purchase | 40,000 | $2.14 | $85,620.00 | 40% 99.66K to 139.66K | |
| 23-Dec-21 6:20 PM View: | Lavizzo-Mourey Risa J Director | Better Therapeutics, Inc. (BTTX) | 21-Dec-21 | Purchase | 10,000 | $4.60 | $46,000.00 | 100% 0 to 10.0K | |
| 22-Dec-21 6:03 PM View: | Appelbaum Kevin J Chief Executive Officer Director 10% Owner | Better Therapeutics, Inc. (BTTX) | 20-Dec-21 | Purchase | 1,000 | $4.60 | $4,599.90 | < 1% 2.41M to 2.41M | |
| 15-Dec-21 4:53 PM View: | Heinen Mark See Remarks | Better Therapeutics, Inc. (BTTX) | 15-Dec-21 | Purchase | 2,333 | $4.70 | $10,953.40 | 30% 7.67K to 10.0K | |
| 17-Dec-21 8:43 PM View: | Appelbaum Kevin J Chief Executive Officer Director 10% Owner | Better Therapeutics, Inc. (BTTX) | 15-Dec-21 | Purchase | 750 | $4.71 | $3,529.88 | < 1% 2.41M to 2.41M | |
| 16-Dec-21 4:32 PM View: | Parker Geoffrey M. Director | Better Therapeutics, Inc. (BTTX) | 14-Dec-21 | Purchase | 20,000 | $4.94 | $98,800.00 | 60% 33.33K to 53.33K |
